SEC Form 4 · accession 0001013606-15-000153
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D McDermott
Officer — Chief Executive Officer · Director
Period of report
Nov 13, 2015
Accepted (ET)
Nov 17, 2015 · 11:09 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 13, 2015 | A | 22,779 | $0.00 | A | 569,825 | D | |
| Common StockF2 | Nov 13, 2015 | F | 8,561 | $9.04 | D | 561,264 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on May 22, 2014. The related goal was achieved and shares vested.
- F2Withholding of shares to satisfy statutory tax withholding obligations related to the vested shares. The Reporting Person made a withholding election on November 13, 2015.